Tag: entrepreneurs
-
Sensor Material Developed to Detect Fuel Vapors
28 March 2016. A University of Utah engineering team designed a new ultra-sensitive material that can detect traces of hydrocarbon fuel or explosive vapors in the air. Researchers from the lab of Ling Zang published their findings earlier this month of the journal ACS Sensors; paid subscription required. Zang, a professor of engineering and materials…
-
New Biotech Begins Work on Enhanced Platinum Cancer Drugs
23 March 2016. A new biotechnology company began work today on developing improved platinum-based treatments for solid tumor cancers. The company, Placon Therapeutics in Cambridge, Massachusetts, is a spin-off enterprise from Tarveda Therapeutics, a developer of biologic cancer drugs. Placon Therapeutics focuses on new treatments for cancer using platinum as a cancer-killing agent that works…
-
Allied-Bristol Licenses NYU Research, Starts New Company
17 March 2016. Allied-Bristol Life Sciences, a joint venture of Allied Minds and Bristol-Myers Squibb, is licensing research from New York University on signaling pathways affecting growth of tumors, for a new company begun under its tutelage. Financial aspects of the deal between Allied-Bristol and NYU were not disclosed. The new enterprise, known as iBeCa…
-
Vibration Technology Developed to Diagnose Back Pain
11 March 2016. Researchers at University of Alberta adapted engineering technologies using vibrations to develop a new way to diagnose spinal problems causing back pain. The team led by Alberta physical therapy professor Greg Kawchuk reported results of tests comparing its technology to MRI in today’s (11 March) issue of the journal Scientific Reports. Kawchuk…
-
Hydrogel Injection Tested to Treat Advanced Artery Disease
9 March 2016. A biomedical engineering team developed an injected hydrogel for advanced cases of peripheral artery disease that in lab animals improved blood flow and muscles in affected limbs. Researchers from University of California in San Diego, led by bioengineering professor Karen Christman, published their findings earlier this year in the Journal of the…
-
Platform Devised for 3-D Engineered Heart, Liver Tissue
8 March 2016. An engineering team at University of Toronto designed and tested in lab animals a technology for growing synthetic heart and liver tissue for drug testing and eventual clinical use. Researchers led by chemical engineering professor Milica Radisic published their findings yesterday (7 March) in the journal Nature Materials; paid subscription required. Radisic…
-
Pain Medication Given FDA Breakthrough Tag
22 February 2016. A new drug to treat moderate to severe pain, now in clinical trials, received a breakthrough designation from the U.S. Food and Drug Administration. The drug, oliceridine, is made by Trevena Inc. in King of Prussia, Pennsylvania. Oliceridine addresses the same pain signals as opioid drugs that affect areas of the brain…
-
$45M Raised by Protein Folding Drug Discovery Company
10 February 2016. A company discovering new treatments that address errant folding of proteins causing neurological disorders raised $45 million in its first venture funding round. Yumanity Therapeutics, a spin-off enterprise from the Whitehead Institute affiliated with MIT, started in December 2014 and aims to discover therapies for neurodegenerative diseases caused by misfolded proteins. Yumanity…
-
Stent Implants Demonstrated to Transmit Brain Activity
9 February 2016. A team of engineers and medical researchers in Australia show it’s possible to safely implant electrodes in the brain to transmit brain activity with a catheter-delivered stent. A description of the device and delivery process with sheep appears in yesterday’s (8 February) issue of the journal Nature Biotechnology (paid subscription required). The…
-
Test IDs Mesothelioma Years Before Symptoms Appear
5 February 2016. A company spun-off from Purdue University designed a test that in a recent study detects cases of mesothelioma, a form of lung cancer, several years before symptoms develop. Results of the study conducted by MorNuCo Laboratories in West Lafayette, Indiana appear in the 22 January issue of the journal Clinical Proteomics. Mesothelioma is…